2-(pyrrolidin-1-yl)propan-1-amine; oxalic acid, 95.0%, 2.5g

N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine, 95.0%, 1g

(2-Chloro-5-fluoropyridin-4-yl)methanol, 95.0%, 5g

2-(1H-indazol-4-yl)acetic acid, 95+%, 1g

2-Chloroanthracene, 95.0%, 250mg

2,4-Dichloro-8-fluoroquinoline, 1g

4'-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1'-biphenyl]-4-carbaldehyde, 97%, 1g

2-(3-Bromopyridin-2-yl)propan-2-ol, 95.0%, 250mg

4-Bromo-5-fluoro-2-((trimethylsilyl)ethynyl)aniline, 98%, 250mg

N,N'-Dicarbobenzoxy-L-cystine>98.0%(T)5g

(S)-2-Acetamido-4-methoxy-4-oxobutanoic acid, 97%, 1g

Nonadecanedioic acid, 97%, 100g

2,4-Diamino-6-(hydroxymethyl)pteridinehydrochloride, 95.0%, 100g